|
MTBP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.56649999999825E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.350800E-04 |
| Normal-vs-Stage2 |
7.80340000000601E-05 |
| Normal-vs-Stage3 |
9.845700E-04 |
| Normal-vs-Stage4 |
4.582900E-03 |
| Stage1-vs-Stage2 |
5.490500E-02 |
| Stage1-vs-Stage3 |
7.744600E-01 |
| Stage1-vs-Stage4 |
5.858000E-01 |
| Stage2-vs-Stage3 |
1.242610E-01 |
| Stage2-vs-Stage4 |
3.168800E-01 |
| Stage3-vs-Stage4 |
7.717600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.158900E-04 |
| Normal-vs-AfricanAmerican |
3.205600E-02 |
| Normal-vs-Asian |
6.538200E-02 |
| Caucasian-vs-AfricanAmerican |
9.083600E-01 |
| Caucasian-vs-Asian |
3.717000E-01 |
| AfricanAmerican-vs-Asian |
4.992000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.205250E-04 |
| Normal-vs-Female |
1.435750E-04 |
| Male-vs-Female |
3.960400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.139900E-03 |
| Normal-vs-Age(41-60Yrs) |
2.14499999999784E-05 |
| Normal-vs-Age(61-80Yrs) |
5.156200E-04 |
| Normal-vs-Age(81-100Yrs) |
1.606970E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.289800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.201000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.261200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.999000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.959400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.145400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.804600E-01 |
| Classical-VS-Follicular |
2.56239999996133E-06 |
| Classical-VS-Other |
1.757790E-01 |
| Classical-VS-Normal |
2.984600E-03 |
| Tall-VS-Follicular |
1.321880E-02 |
| Tall-VS-Other |
2.403800E-01 |
| Tall-VS-Normal |
5.106300E-02 |
| Follicular-VS-Other |
8.585400E-01 |
| Follicular-VS-Normal |
1.37649999953915E-07 |
| Other-VS-Normal |
3.363700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.91810000005344E-06 |
| Normal-vs-N1 |
7.554100E-02 |
| N0-vs-N1 |
3.564400E-02 |
|
|
